0000899243-21-003963.txt : 20210201
0000899243-21-003963.hdr.sgml : 20210201
20210201212317
ACCESSION NUMBER: 0000899243-21-003963
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210128
FILED AS OF DATE: 20210201
DATE AS OF CHANGE: 20210201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOTTSCHALK ADRIAN
CENTRAL INDEX KEY: 0001828724
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39634
FILM NUMBER: 21578681
MAIL ADDRESS:
STREET 1: 100 BINNEY STREET
STREET 2: SUITE 610
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foghorn Therapeutics Inc.
CENTRAL INDEX KEY: 0001822462
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-586-3100
MAIL ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-28
0
0001822462
Foghorn Therapeutics Inc.
FHTX
0001828724
GOTTSCHALK ADRIAN
500 TECHNOLOGY SQUARE, STE 700
CAMBRIDGE
MA
02139
1
1
0
0
See Remarks
Stock Option (Right to Buy)
16.63
2021-01-28
4
A
0
300000
0.00
A
2031-01-27
Common Stock
300000
300000
D
The options will vest as to 25% of the underlying shares of common stock on January 28, 2022, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.
President & Chief Executive Officer
/s/ Allan Reine, M.D., Attorney-in-Fact
2021-02-01